Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-009173
Filing Date
2025-01-27
Accepted
2025-01-27 16:03:06
Documents
1
Period of Report
2025-01-23

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5419
  Complete submission text file 0000950170-25-009173.txt   6812
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Issuer) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3201 CARNEGIE AVENUE CLEVELAND OH 44115-2634
Business Address
Macleod ivor (Reporting) CIK: 0001800734 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36365 | Film No.: 25558948